newsfilter
← Latest News
PR Newswire·

Synaptogenix Announces Live Appearance of its President and CSO on Streaming Financial News Network

NEW YORK, June 24, 2021 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Dr. Daniel Alkon, the Company's President and Chief Sci